Lupus anticoagulants and antiphospholipid antibodies |
| |
Authors: | P Thiagarajan SS Shapiro |
| |
Affiliation: | Department of Internal Medicine, University of Texas Health Science Center, Houston, USA. |
| |
Abstract: | In recent years, clinical syndromes involving lupus anticoagulants and antiphospholipid antibodies have come into increasing clinical prominence. Since the discovery that most antiphospholipid antibodies require the presence of anionic phospholipid-binding proteins such as B2-glycoprotein I and prothrombin, a large number of studies have attempted to delineate the specificity of these antibodies. Several mechanisms have been proposed to explain the hypercoagulable state associated with these antibodies. This review attempts to summarize these data and the challenges that confront efforts to delineate the pathogenesis of the prothrombotic state associated with the presence of these antibodies. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|